Director at TrueBlue (TBI) receives 29,097-share restricted stock unit grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

TrueBlue, Inc. director Colleen B. Brown reported an equity award of 29,097 shares of Common Stock at a stated price of $0.00 per share. A footnote explains this represents a grant of restricted stock units that will convert into shares on a one-for-one basis and vest in full one year from the grant date. Following this award, her directly held Common Stock balance is 89,112 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BROWN COLLEEN B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,097	$0.00	--

Holdings After Transaction: Common Stock — 89,112 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/24/2026 - 10:44 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROWN COLLEEN B

(Last)

(First)

(Middle)

1015 A STREET

(Street)

TACOMA

98402

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/20/2026		A		29,097⁽¹⁾	A	$0	89,112	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares acquired represent a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date.

Remarks:

	/s/ Todd N. Gilman, Attorney-in-fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did TrueBlue (TBI) disclose in this Form 4?

TrueBlue reported that director Colleen B. Brown acquired 29,097 shares of Common Stock as an equity award. The filing labels the transaction as a grant or other acquisition, with a stated price of $0.00 per share and direct ownership reported after the grant.

How many TrueBlue (TBI) shares did Colleen B. Brown receive?

Colleen B. Brown received 29,097 shares tied to Common Stock, according to the Form 4. The transaction is coded as a grant, award, or other acquisition, reflecting an equity compensation award rather than an open-market purchase or sale of existing TrueBlue shares.

What does the Form 4 footnote say about the TrueBlue (TBI) award?

The footnote states the acquired shares represent a grant of restricted stock units that will be settled for Common Stock on a one-for-one basis in the future. It further explains these restricted stock units will vest in full one year from the grant date provided in the filing.

Is the TrueBlue (TBI) Form 4 transaction a market purchase or a stock grant?

The filing describes the transaction as a grant, award, or other acquisition, not an open-market purchase. The reported price per share is $0.00, and a footnote clarifies the award consists of restricted stock units that will later settle into shares of TrueBlue Common Stock.

How many TrueBlue (TBI) shares does Colleen B. Brown own after this grant?

After the reported grant, Colleen B. Brown holds 89,112 shares of TrueBlue Common Stock directly. This total comes from the Form 4 line showing the number of securities beneficially owned following the transaction, reflecting her direct ownership position after the equity award.

When do the TrueBlue (TBI) restricted stock units reported in the Form 4 vest?

The restricted stock units reported in the Form 4 will vest in full one year from the grant date. The footnote explains that once vested, these units will be settled on a one-for-one basis into shares of TrueBlue Common Stock, increasing the director’s share holdings.